Taiwan’s indigenously developed Medigen COVID-19 vaccine is as effective in preventing deaths and serious symptoms as mRNA shots, a study to be published in the US Centers for Disease Control and Prevention’s journal next month showed.
An early release of the study is available on the Web site of the Emerging Infectious Diseases journal.
The study, conducted by the Centers for Disease and Control (CDC), utilized data from Taiwan’s records of inoculations, hospitalizations and deaths since the local outbreak of the Omicron variant of SARS-CoV-2 in 2022.
Photo: Taipei Times
CDC Deputy Director-General Philip Lo (羅一鈞) said that the protein subunit-based Medigen vaccine had an effectiveness of 91 percent after three jabs.
The mRNA-based BioNTech and Moderna vaccines were 95.8 and 81 percent effective after three jabs respectively, while the viral vector-based AstraZeneca vaccine was 65.7 percent effective, Lo said.
The CDC study also found that Medigen and mRNA jabs had a longer efficacy period than the AstraZeneca vaccine, he said.
The research is the world’s first big data study on the efficacy of mRNA, protein-subunit and viral-vector COVID-19 vaccines that draw from real-world outcomes, he said, adding that the findings might boost the development of new protein-subunit vaccines, including Novavax.
The study vindicates the Medigen vaccine, which was unfairly criticized in the nation, Premier Chen Chien-jen (陳建仁) told an event marking the inking of a strategic alliance between Taiwan Bio-Manufacturing Corp (台灣生物醫藥製造) and US-based National Resilience Inc.
Taiwan handled its local outbreak with a conventional strategy, which proved successful in containing the virus’ spread and protecting economic growth, he said, adding that the nation has received international accolades for its accomplishment.
The COVID-19 pandemic showed that having pharmaceutical research capability without an industrial base to manufacture medicines at scale would not be enough to meet Taiwan’s needs, National Development Council Minister Kung Ming-hsin (龔明鑫) said.
The ability to mass produce medical drugs is crucial to public health as well as national security, but the nation’s NT$1 trillion (US$32.01 billion) biomedical industry has an undersized NT$700 billion to NT$800 billion manufacturing sector, he said.
Separately yesterday, Lo said that the CDC had delivered the last 156,000 Novavax XBB doses in its inventory to local governments.
The number of available Moderna and Novavax XBB vaccine doses stood at 459.2 million and 315,000 respectively, he said.
COVID-19 continues to circulate, with 52 percent of cases now being the JN.1 variant, Lo said, adding that XBB vaccines are about 50 percent effective against mild symptoms in adults.
The CDC urged the public to get inoculated ahead of the Lunar New Year holiday, which begins next week.
People older than 12 can get either type of the XXB vaccine, while children under that age can only receive Moderna’s version, it said.
Information about vaccination locations can be found online at: https://gov.tw/eU4.
Additional reporting by CNA
DEATH THREAT: A MAC official said that it has urged Beijing to avoid creating barriers that would impede exchanges across the Strait, but it continues to do so People should avoid unnecessary travel to China after Beijing issued 22 guidelines allowing its courts to try in absentia and sentence to death “Taiwan independence separatists,” the Mainland Affairs Council (MAC) said yesterday as it raised its travel alert for China, including Hong Kong and Macau, to “orange.” The guidelines published last week “severely threaten the personal safety of Taiwanese traveling to China, Hong Kong and Macau,” MAC Deputy Minister and spokesman Liang Wen-chieh (梁文傑) told a news conference in Taipei. “Following a comprehensive assessment, the government considers it necessary to elevate the travel alert to orange from yellow,” Liang said. Beijing has
Chinese President Xi Jinping (習近平) yesterday said that the Chinese Communist Party was planning and implementing “major” reforms, ahead of a political conclave that is expected to put economic recovery high on the agenda. Chinese policymakers have struggled to reignite growth since late 2022, when restrictions put in place due to the COVID-19 pandemic were lifted. The world’s second-largest economy is beset by a debt crisis in the property sector, persistently low consumption and high unemployment among young people. Policymakers “are planning and implementing major measures to further deepen reform in a comprehensive manner,” Xi said in a speech at the Great Hall
CIVIL DEFENSE: More reservists in alternative service would help establish a sound civil defense system for use in wartime and during natural disasters, Kuma Academy’s CEO said While a total of 120,000 reservists are expected to be called up for alternative reserve drills this year, compared with the 6,505 drilled last year, the number has been revised to 58,000 due to a postponed training date, Deputy Minster of the Interior Ma Shih-yuan (馬士元) said. In principle, the ministry still aims to call up 120,000 reservists for alternative reserve drills next year, he said, but the actual number would not be decided later until after this year’s evaluation. The increase follows a Legislative Yuan request that the Ministry of the Interior address low recruitment rates, which it made while reviewing
SOLUTIONS NEEDED: Taiwan must attract about 400,000 to 500,000 skilled foreign workers due to population decline, the minister of economic affairs said in Washington President William Lai’s (賴清德) administration is considering a plan to import labor to deal with an impending shortage of engineers and other highly skilled workers, Minister of Economic Affairs J.W. Kuo (郭智輝) said in Washington on Tuesday. Kuo was leading a delegation attending the SelectUSA Investment Summit. Taiwan must attract about 400,000 to 500,000 skilled foreign workers for high-end manufacturing jobs by 2040, he said. Ministry of Economic Affairs officials are still calculating the precise number of workers that are needed, as it works on loosening immigration restrictions and creating incentives, Kuo said. Taiwanese firms operating factories in the US and other countries would